156 related articles for article (PubMed ID: 28698189)
1. A comprehensive review on MEN2B.
Castinetti F; Moley J; Mulligan L; Waguespack SG
Endocr Relat Cancer; 2018 Feb; 25(2):T29-T39. PubMed ID: 28698189
[TBL] [Abstract][Full Text] [Related]
2. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
3. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
[TBL] [Abstract][Full Text] [Related]
4. The Reality of Multiple Endocrine Neoplasia Type 2B Diagnosis: Awareness of Unique Physical Appearance Is Important.
Nagaoka R; Sugitani I; Sanada M; Jikuzono T; Okamura R; Igarashi T; Akasu H; Shimizu K
J Nippon Med Sch; 2018; 85(3):178-182. PubMed ID: 30135345
[TBL] [Abstract][Full Text] [Related]
5. A Novel Double
Mathew A; Latteyer S; Frank-Raue K; Moeller LC; Zwanziger D; Mengel M; Führer D; Tiedje V
Thyroid; 2021 Feb; 31(2):327-329. PubMed ID: 32546069
[No Abstract] [Full Text] [Related]
6. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.
Nakao KT; Usui T; Ikeda M; Mori Y; Yamamoto T; Kawashima ST; Nanba K; Yuno A; Tamanaha T; Tagami T; Naruse M; Asato R; Shimatsu A
Head Neck; 2013 Dec; 35(12):E363-8. PubMed ID: 23468374
[TBL] [Abstract][Full Text] [Related]
7. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
[TBL] [Abstract][Full Text] [Related]
8. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
Camacho CP; Hoff AO; Lindsey SC; Signorini PS; Valente FO; Oliveira MN; Kunii IS; Biscolla RP; Cerutti JM; Maciel RM
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1393-8. PubMed ID: 19169500
[TBL] [Abstract][Full Text] [Related]
10. MEN2B syndrome - paediatric case report.
Zendran I; Szlasa W; Bis G; Sondaj K; Barg E
Pediatr Endocrinol Diabetes Metab; 2020; 26(4):211-215. PubMed ID: 33191720
[TBL] [Abstract][Full Text] [Related]
11. Cystic ovarian teratoma as a novel tumor and growth hormone deficiency as a new condition presenting in Multiple Endocrine Neoplasia type 2B: Case reports and review of the literature.
Pomahacova R; Paterova P; Nykodymova E; Vaclavikova E; Sykorova P; Personova K; Katra R; Subrt I; Sykora J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Mar; 166(1):105-111. PubMed ID: 34446941
[TBL] [Abstract][Full Text] [Related]
12. RET proto oncogene mutation detection and medullary thyroid carcinoma prevention.
Yeganeh MZ; Sheikholeslami S; Hedayati M
Asian Pac J Cancer Prev; 2015; 16(6):2107-17. PubMed ID: 25824727
[TBL] [Abstract][Full Text] [Related]
13. [Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].
Mathiesen JS; Døssing H; Bender L; Godballe C
Ugeskr Laeger; 2014 Jan; 176(5A):. PubMed ID: 27498810
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
15. Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.
Brauckhoff M; Machens A; Lorenz K; Bjøro T; Varhaug JE; Dralle H
Ann Surg; 2014 Apr; 259(4):800-6. PubMed ID: 23979292
[TBL] [Abstract][Full Text] [Related]
16. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?
Wray CJ; Rich TA; Waguespack SG; Lee JE; Perrier ND; Evans DB
Ann Surg Oncol; 2008 Jan; 15(1):293-301. PubMed ID: 17963006
[TBL] [Abstract][Full Text] [Related]
17. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
Frank-Raue K; Rondot S; Schulze E; Raue F
Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401
[TBL] [Abstract][Full Text] [Related]
18. Prostate adenocarcinoma in a young patient with multiple endocrine neoplasia 2B.
Maqdasy S; Costes-Chalret N; Batisse-Lignier M; Baron S; Tauveron I
Ann Endocrinol (Paris); 2018 Apr; 79(2):86-89. PubMed ID: 29530270
[No Abstract] [Full Text] [Related]
19. Spontaneous and Treatment-Related Changes of Serum Calcitonin in Medullary Thyroid Cancer: Long-Term Experience in a Patient With Multiple Endocrine Neoplasia Type 2B.
Réti Z; Tabák ÁG; Garami M; Kalina I; Kiss G; Sápi Z; Tóth M; Tőke J
JCO Precis Oncol; 2024 May; 8():e2300675. PubMed ID: 38709988
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.
Raue F; Dralle H; Machens A; Bruckner T; Frank-Raue K
J Clin Endocrinol Metab; 2018 Jan; 103(1):235-243. PubMed ID: 29077903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
